pharmiweb.com today archive

ICON plc a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Professor Brendan Buckley and Dr. Nicholas Alp to the company’s Global Scientific Council. ICON’s Scientific Council is a team of ICON experts with broad industry experience and knowledge of the scientific, technical and therapeutic aspects of product development, from concept through to approval.

Professor Brendan Buckley has been appointed Senior Vice President, Medical Affairs, having joined ICON in July 2011 through the company’s acquisition of Firecrest Clinical. An endocrinologist with over 30 years’ experience, Professor Buckley is Honorary Professor of Medicine and Pharmacology at the School of Medicine, University College Cork (UCC), Ireland. He has been a Board member of the Irish Medicines Board and of the EMA’s Scientific Advisory Group for Diabetes and Endocrinology since 2005. He was also a member of the EMA Committee for Orphan Medicinal Products from 2000-2003 and a member of the EMA’s panel of experts. Professor Buckley chairs several independent Data and Safety Monitoring Boards in cardio-metabolic disease and in rare diseases.
Read the full story here.